Browsing by Subject "Growth factors"

Now showing 1 - 6 of 6
  • Thumbnail Image
    Publication
    Open Access
    Adipose-derived stem cells and adipose-derived stem cell-conditioned medium modulate in situ imbalance between collagen I- and collagen V-mediated IL-17 immune response recovering bleomycin pulmonary fibrosis
    (Universidad de Murcia, Departamento de Biologia Celular e Histiologia, 2020) Gonçalves Felix, Renato; Carvalho Bovolato, Ana Livia; Cotrim, Ondina Silvia; Leão, Patricia dos Santos; Batah, Sabrina Setembre; Golim, Márjorie de Assis; Velosa, Ana Paula P.; Teodoro, Walcy; Martins, Vanessa; Ferreira Cruz, Fernanda; Deffune, Elenice; Fabro, Alexandre Todorovic; Capelozzi, Vera Luiza
    The immunogenic collagen V (Col V) and the proinflammatory cytokine interleukin (IL)-17 have been implicated in the pathogenesis of multiple autoimmune diseases. Col V is also up-regulated during adipogenesis and can stimulate adipocyte differentiation in vitro. Conditioned medium (CM) generated from adipose- derived mesenchymal stem cells (MSCs) reduces bleomycin (BLM)-induced lung injury in rats, suggesting a crucial role in situ of immunomodulatory factors secreted by MSCs in these beneficial effects. In the present work, we investigated this hypothesis, analyzing levels of plasma inflammatory mediators and inflammatory and fibrotic mediators in the lung tissue of BLM-injured rats after treatment with MSCs and CM. Pulmonary fibrosis was intratracheally induced by BLM. After 10 days, BLM animals were further randomized into subgroups receiving saline, MSCs, or CM intravenously. On days 14 and 21, the animals were euthanized, and the lungs were examined through protein expression of nitric oxide synthase (NOS), IL-17, transforming growth factor-β (TGF-β), vascular endothelial growth factor, endothelin-1, and the immunogenic Col V through histological quantitative evaluation and plasma levels of fibrinogen, Von Willebrand factor, and platelet-derived growth factor (PDGF). Rats that had been injected with MSCs and CM showed a significant increase in weight and significant improvements at 14 and 21 days after intravenous injection at both time points of analysis of plasma fibrinogen, PDGF, and Von Willebrand factor and NOS-2 expression, supporting an early anti-inflammatory action, thus reducing TGF-β and collagen I fibers. In contrast, intravenous injection of CM was able to significantly increase the deposition of Col V fibers and IL-17 on both day 14 and day 21 as compared with the amount observed in rats from the BLM group and MSC groups. In conclusion, this study reinforces previous observations on the therapeutic properties of MSCs and CM and is the first report to demonstrate the association of its actions with immunomodulatory biomarkers on lung tissue. We concluded that adipose-derived stem cells and adipose- derived stem cells-CM modulate an in situ imbalance between collagen I- and Col V-mediated IL-17 immune response, emerging as a promising therapeutic option for recovering from BLM pulmonary fibrosis
  • Thumbnail Image
    Publication
    Open Access
    Dynamic interactions of the extracellular matrix
    (Murcia : F. Hernández, 1996) Slater, M.
    The extracellular matrix (ECM) is a dynamic assemblage of interacting molecules that reorganise and regulate cell functions in response to endogenous and exogenous stimulii. Matrix components may affect cell behaviour directly or indirectly through growth factor sequestration and transmembrane signalling, by controlling the speed of various molecules through the ECM, and the access of growth factors, hormones and neurotransmitters to the cell surface.
  • Thumbnail Image
    Publication
    Open Access
    Empleo de células madre en el tratamiento de lesiones tendinosas en el caballo de deporte
    (Universidad de Murcia, 2014) Diego, R.
    Los caballos presentan un potente aparato tendinoso en la región distal de sus extremidades que se originan en los sistemas musculares que se disponen proximalmente al carpo o tarso y se insertan en la falange distal. Como consecuencia de las exigencias deportivas a las que están sometidos los caballos, son frecuentes las lesiones tendinosas que comprometen su vida deportiva. Tradicionalmente, el tratamiento se ha basado en regeneradores de la matriz extracelular (polisulfato glicosaminoglicano, ácido hialurónico) o inhibidores del colágeno (β-aminopropionitrilo de fumarato) combinado con reposo, con unos resultados limitados. Es por ello que en la última década se han desarrollado opciones terapéuticas basadas en la medicina regenerativa y la terapia celular, permitiendo la recuperación funcional de la estructura lesionada mediante el uso de células madre mesenquimales (MSCs). En este artículo se revisa el estado actual de la terapia celular con MSCs como tratamiento de lesiones tendinosas en caballos de deporte. A nivel de terapia celular destaca el uso de células madre mesenquimales de origen óseo y adiposo, con unos resultados de recuperación realmente alentadores con respecto a caballos mantenidos en reposo, que se traduce en la presencia en la zona lesionada de un mayor porcentaje de colágeno tipo I, menor cantidad de agua y glucosaminoglicanos y disminución del infiltrado inflamatorio; también se ha descrito un aumento en la neovascularización. En cuanto a las propiedades biomecánicas, los tendones tratados con células madre tienen menor rigidez y mejor organización fibrilar que los tratados de forma clásica, apreciándose también mejoras en la elasticidad. Los datos que ofrecen los últimos estudios, muestran que de los animales tratados con MSCs (n=113), el 98,2% volvió a la vida deportiva. De este 98,2% de caballos, el 27,4% presentó recidivas y el 5,3% tuvo una lesión tendinosa en la extremidad contralateral. Sin embargo, no se han encontrado diferencias en la resolución de tendinopatías tratadas con MSCs por edad ni por sexo. Aunque los resultados de los primeros estudios sean favorables, hasta la fecha, la falta de estandarización de los protocolos y el número reducido de animales estudiados no permiten alcanzar conclusiones definitivas.
  • Thumbnail Image
    Publication
    Open Access
    Histological evaluation of scar tissue inflammatory response: the role of hGH in diabetic rats
    (Murcia : F. Hernández, 2005) García-Esteo, F.; Pascual, G.; García-Honduvilla, N.; Gallardo, A.; San-Román, J.; Bellón, J.M.; Buján, J.
    This paper describes a polymer site-specific delivery system containing human growth hormone in an in vivo model of scarring in the diabetic state. Copolymer discs with the hormone were introduced into incisions made in rats previously injected with streptozotocin in order to induce diabetes. Tissue specimens for evaluation were obtained at 3, 7 or 10 days after the procedure. Study groups were healthy rats and diabetic rats untreated or treated with/without the hormone. Histological sections were prepared for light microscopy examination of wound zones. Three and 7 days after surgery, polymer remains could be observed in the subcutaneous tissue. These remnants induced a moderate foreign body reaction. The number of macrophages detected was directly related to neovessel formation and metalloelastase expression. The CD4+/CD8+ ratio was low during the initial follow up stages (3 and 7 days) in untreated diabetic rats, yet an increased ratio corresponding to areas around the polymer remains was noted in the animals treated with copolymer loaded with the growth hormone. Copolymer is biodegradable in vivo and may be used as a vehicle for the slow release of active substances. The presence of the hormone at the site of skin injury induces cell proliferation and enhances the repair process.
  • Thumbnail Image
    Publication
    Open Access
    In vitro maturation of human primordial ovarian follicles. Clinical significance, progress in mammals, and methods for growth evaluation
    (Murcia : F. Hernández, 2006) Abir, R.; Nitke, S.; Ben-Haroush, A.; Fisch, B.
    As cancer treatment improves, more young women of reproductive age are surviving, but they suffer from infertility as a consequence of the radiation and chemotherapy. Human ovarian tissue containing immature primordial follicles has been successfully cryopreserved. The ultimate aim of this technique is to induce ovarian function by re-plantation of ovarian tissue or, further into the future, by in vitro maturation (IVM) of the oocytes derived from the cryopreservedthawed ovarian tissue, followed by routine in vitro fertilization. IVM of primordial follicles from young cancer survivors would avoid the risk of cancer retransmission by the ovarian grafts. The present review discusses the current achievements in IVM of female germ cells and primordial ovarian follicles and the attempts to improve their development by adding various factors to the culture medium. The established methods for the evaluation of survival and growth in culture are also discussed: follicular counts, immunocytochemical methods, transmission electron microscopy, fluorescent viability markers and endocrine assays. Although the development of IVM systems is still in its infancy, researchers need to pursue their approach step-by-step, especially with regard to factors that might be involved in the activation of the ovarian follicles or female germ cells. The final measure of success will be the ability of the in vitro matured oocytes to fertilize and produce healthy offsprings. The availability of such treatment will probably lead to its demand not only by cancer patients but by other women as well.
  • Thumbnail Image
    Publication
    Open Access
    Recent advances in hypertrophic scar
    (Universidad de Murcia. Departamento de Biología Celular e Histología, 2018) Zhang, Julei; Li, Yan; Bai, Xiaozhi; Li, Yuehua; Shi, Jihong; Hu, Dahai
    Hypertrophic scars (HTS) are predominant diseases after burn and trauma, which cause severe physiological and psychological problems. HTS have been researched for decades, and our knowledge about the mechanisms of HTS formation process has been increasing. However, the effects of currently available prevention and treatment strategies are limited. In this review, we summarize currently known mechanisms and recent studies of HTS, including extracellular matrix, matrix metalloproteinases, fibroblasts, myofibroblasts and their contraction ability, keratinocytes, growth factors, inflammatory and immune response, and stem cell treatment, hoping for a better understanding of HTS generation, development and effective translation to treatment strategies.